Plus, Paul Rickard joins us to talk about Xero's recent $3.9 billon acquisition.
Subscribe to Switzer
- Switzer Report - https://switzerreport.com.au/subscribe
- Switzer Daily - https://switzer.com.au/subscribe
Plus, Paul Rickard joins us to talk about Xero's recent $3.9 billon acquisition.
We got our stock pickers to show us three stocks each that they're eyeing in the new year. Here are their new financial year stocks. Plus: what's going to happen with house pricing in the near-term?
Peter Switzer talks to CEOs and a CFO from some of the biggest companies reporting in the past week, plus a catch up with Julia Lee.
Dr Ross Walker explains two promising COVID-19 vaccine trials and what they have been able to achieve.
Tune in to find out the latest money news locally and overseas with Peter Switzer and Paul Rickard.
Peter Switzer speaks to Burman Invest's Julia Lee and Shaw and Partners' Adam Dawes about what companies to watch, plus Ruslan Kogan joins the show.
Dr Ross Walker shares the details of a treatment plan with positive results in some mild to moderate cases of Coronavirus.
Find out the major money news of the day and how it affects you with Peter Switzer and Paul Rickard.
On this week's show: Burman Invest's Julia Lee, Fairmont Equities' Michael Gable, ELMO's Danny Lessem, Morgans' Raymond Chan and Switzer's Paul Rickard.
Dr Ross explains herd immunity and how it could work in the case of COVID-19.
Catch up with Peter Switzer and Paul Rickard for the latest money news locally and overseas.
Fortescue CEO Elizabeth Gaines joins this week's show, along with Burman Invest's Julia Lee, Shawn and Partners' Adam Dawes and Switzer's Paul Rickard.
Dr Ross Walker shares his criticisms about how the coronavirus pandemic has been handled.
Peter Switzer and Paul Rickard discuss masking up for the economy, rising gold prices and the looming reporting season.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox